Follow The Filings

ODTX Odyssey Therapeutics

Odyssey Therapeutics earnings company data as of 10:00 AM ET 10/23

Limited consensus data for this ticker (thin coverage or data-plan limits). Dates may be company-announced rather than sell-side consensus. Calendar and recent prints remain the primary lens when available.

Scheduled

1 period, newest first, nothing reported yet. Each row shows EPS above revenue.

Period Date Metric Estimate Actual Result
FY2026 Q3 4 Nov EPS — — —
Rev — — —

Insider trades

Open-market buys and sales by ODTX's executives, directors and 10% owners in the last 12 months, from their Form 4s

All ODTX insider trades
  • $75.3M bought by 7 insiders
  • $32K sold by 1 insider outside a trading plan
  • None no planned (10b5-1) sales
  1. Tpg Gp A, LLC Insider, +2 joint filers
    Buy
    $25M 1,388,889 shares at $18.00 +60% to stake
    Traded May 11 Filed May 13
  2. Dimension Capital II, L.P. Director
    Buy
    $20M 1,111,111 shares at $18.00 +50% to stake
    Traded May 8 Filed May 12
  3. Sr One Capital Management, LLC 10% owner, +1 joint filer
    Sale
    $32K 1,780 shares at $18.00 0.2% of stake
    Traded May 11 Filed May 11
  4. Sr One Capital Management, LLC 10% owner, +1 joint filer
    Buy
    $10M 555,555 shares at $18.00 +121% to stake
    Traded May 11 Filed May 11
  5. Jeffrey M Leiden Director
    Buy
    $100K 5,000 shares at $20.00 +1.9% to stake
    Traded May 8 Filed May 11
  6. Jason Haas CFO
    Buy
    $20K 1,000 shares at $20.00 +1.6% to stake
    Traded May 8 Filed May 11
  7. Nan (ln) Li Director
    Buy
    $20M 1,111,111 shares at $18.00 +50% to stake
    Traded May 11 Filed May 11
  8. Shelley Chu Director
    Buy
    $200K 11,111 shares at $18.00 New stake
    Traded May 11 Filed May 11

Also filed in the last 12 months, not counted as buying or selling: 18 conversions, 5 option exercises, 2 share withholdings for taxes, and 2 other transactions.

SEC filings

Recent issuer filings from EDGAR, 18 shown.

Filed Form Detail Links
8-K 7.01,9.01
8-K 7.01,9.01
10-Q
8-K 2.02,9.01
8-K 7.01,9.01
8-K 2.02,9.01
10-Q
SCHEDULE 13G —
SCHEDULE 13D —
SCHEDULE 13D —
SCHEDULE 13G —
SCHEDULE 13D —
SCHEDULE 13D —
8-K 1.01,3.02,5.03,9.01
424B4
S-1/A
S-1
S-1

Estimates are consensus figures; SEC filings remain the official record. Not investment advice.